My take is a little different, Bio-Gene in July made an announcement regarding Qcide's efficacy on mosquitos targeting consumer applications.
This announcement is expanding studies to now include vector control and crop protection, in addition to consumer applications. As several key companies are looking to explore natural alternatives and have shown interest.
It sounds like we will see a deal in the New Year as these results come to hand and Bio-Gene are able to offer partnership agreements with Flavocide and Qcide across all verticals.
Qcide works, heres an old video showing how quickly it is able to knockdown flies and mosquitos.
Its a shame this compound wasn't given any proper focus or scientific rigour when it was licensed out to BioProspects in the mid 2000s.
The good news is many previous directors are still holding strong and see the future. It has finally been capitalised and theres arguably been more progress over the past year in terms of testing and results, than any previous progress over the past decade.
2019 is set to be transformative for the company.
BGT Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
